Associated Papers
HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHES.
Sharifi N et al.
Cell Reports. Medicine, 2024
39168093 (PubMed )
Supplement: mmc2.pdf
Select a paper to view details